...
首页> 外文期刊>The Professional Medical Journal >ALKALINE PHOSPHATASE; Total serum alkaline phosphatase (ALP) as a predictor of bone metastasis among patients having carcinoma breast at a tertiary care hospital
【24h】

ALKALINE PHOSPHATASE; Total serum alkaline phosphatase (ALP) as a predictor of bone metastasis among patients having carcinoma breast at a tertiary care hospital

机译:碱性磷酸酶;三级医院乳腺癌患者总血清碱性磷酸酶(ALP)可预测骨转移

获取原文

摘要

Background: This study was carried out to determine the role of total serumalkaline Phosphatase in bone metastasis among patients of breast cancer. Setting; Departmentof Surgery, Nishtar Medical University, Multan in collaboration with breast clinic MINAR. StudyDuration; January 2016 to June 2017 Subjects and methods; It was a retrospective studycarried out at breast clinic MINAR, Multan. The medical record of the female patients havingbreast cancer aged 25 to 70 years (who presented from January 2016 to June 2017) wasscrutinized. All the registered patients during above mentioned period having breast carcinomawith metastatic bone disease, as depicted on bone scan, were taken as index cases. All thecases underwent total serum alkaline Phosphatase estimation. We collected 86 cases for thisresearch study. Primary bone tumours, lymphomas, sarcomas and bone metastasis due toother primary visceral malignancies were excluded. All the required data were entered andanalyzed using computer program SPSS version 20.0. Results; The mean age of the breastcancer patients was 46.51 ± 11.11 years (ranging from 25 – 70 years). Eighty four (97.7%) weremarried. All the patients presented with lump breast. Only 3 (3.5%) of the cases gave familyhistory of breast cancer and history of contraceptive pills was positive in 4 (3.7%) of the cases.History of breast feeding was positive in 63 (73.3%) of the cases. Mean age at menarche was13.21± 0.896 years in our study cases. Mean age at menopause in our study was 46.86 ±5.66 years. Total serum alkaline Phosphatase was raised in 27 (31.4%) cases. Only 6 (6.9%) ofthe cases showed its level more than 500 IU/L. Conclusion; Our study results don’t favor totalserum alkaline Phosphatase estimation as biological marker of bone metastasis among breastcancer patients. Bone scan is more reliable and hence be employed for detection of bonemetastasis. Further studies on bone ALP and total ALP estimation are required to generatefurther evidence on this subject.
机译:背景:本研究旨在确定血清总碱性磷酸酶在乳腺癌患者骨转移中的作用。设置; Nishtar医科大学木尔坦分院外科与乳腺癌诊所MINAR合作。 StudyDuration; 2016年1月至2017年6月的主题和方法;这项回顾性研究是在Multan的乳房诊所MINAR进行的。审查了年龄在25至70岁之间的女性乳腺癌患者的病历(从2016年1月至2017年6月出示)。如在骨扫描中所描绘的,在上述期间内所有登记的患有转移性骨疾病的乳腺癌的患者均作为指标病例。所有病例均进行血清总碱性磷酸酶估计。我们收集了86例用于本研究的病例。排除由于其他原发性内脏恶性肿瘤引起的原发性骨肿瘤,淋巴瘤,肉瘤和骨转移。使用计算机程序SPSS 20.0版输入并分析所有必需的数据。结果;乳腺癌患者的平均年龄为46.51±11.11岁(25至70岁)。已婚84位(97.7%)。所有患者均出现乳房肿块。仅有3例(3.5%)有乳腺癌家族史,避孕药史阳性4例(3.7%);母乳喂养史63例(73.3%)为阳性。在我们的研究病例中,初潮的平均年龄为13.21±0.896岁。在我们的研究中,更年期的平均年龄为46.86±5.66岁。 27例(31.4%)患者血清总碱性磷酸酶升高。仅6例(6.9%)的病例显示其水平超过500 IU / L。结论;我们的研究结果不建议将总血清碱性磷酸酶评估作为乳腺癌患者骨转移的生物学指标。骨扫描更可靠,因此可用于检测骨转移。需要对骨ALP和总ALP估计值进行进一步研究,以得出有关该主题的更多证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号